KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Net Margin (2016 - 2025)

Evolent Health (EVH) has 11 years of Net Margin data on record, last reported at 2257.8% in Q4 2025.

  • For Q4 2025, Net Margin rose 226254.0% year-over-year to 2257.8%; the TTM value through Dec 2025 reached 41.73%, down 3808.0%, while the annual FY2025 figure was 930.1%, 93134.0% up from the prior year.
  • Net Margin reached 2257.8% in Q4 2025 per EVH's latest filing, up from 5.62% in the prior quarter.
  • Across five years, Net Margin topped out at 2257.8% in Q4 2025 and bottomed at 14.94% in Q1 2025.
  • Average Net Margin over 5 years is 107.99%, with a median of 4.65% recorded in 2021.
  • The widest YoY moves for Net Margin: up 226254bps in 2025, down -1099bps in 2025.
  • A 5-year view of Net Margin shows it stood at 2.27% in 2021, then plummeted by -31bps to 2.97% in 2022, then crashed by -151bps to 7.44% in 2023, then surged by 36bps to 4.74% in 2024, then surged by 47749bps to 2257.8% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 2257.8% in Q4 2025, 5.62% in Q3 2025, and 11.5% in Q2 2025.